Sabra Healthcare REIT

SBRA

Market cap $5.18B

Sabra Health Care remains a Buy, supported by strong SHOP expansion, robust guidance, and a sustainable 5.84% dividend yield. SBRA projects 4.9%-5.4% FFO growth and plans over $450 million in investments for 2026, with a solid pipeline and a good debt schedule. Leverage is steady at 5x, with recent refinancing extending maturities and reducing interest costs, supporting financial flexibility.

Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #CITI--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer; Michael Costa, the company's Chief Financial Officer; Darrin Smith, the company's Chief Investment Officer; and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Citi's 2026 Global Property CEO Conference on March 1-4, 2026, at The Diplomat Beach Resort in Hollywood, Florida. About Sabra Sabra Health Care REI.

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the fourth quarter of 2025. FOURTH QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2025 were as follows: Net Income: $0.11 FFO: $0.36 Normalized FFO: $0.36 AFFO: $0.37 Normalized AFFO: $0.38 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.38x Senior Housing - Leased: 1.52x Beh.

NAV Monitor: U.S. REITs End January At Median 16.2% Discount To Net Asset Value

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #4Q25--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2025 fourth quarter earnings release on February 12, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 fourth quarter results will be held on Friday, February 13 at 11:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference.

Sabra Health Care REIT is rated Buy, with substantial upside driven by its accelerated transition to the SHOP operating model and attractive valuation. SBRA targets 40% SHOP portfolio exposure, expecting to exceed their up to $500M investment guidance, positioning for robust growth into 2026. Normalized AFFO guidance for 2025 is $1.495/share, with an 80% payout ratio supporting a 6.38% dividend yield and potential for future increases.

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2025tax--Sabra Health Care REIT, Inc. (NASDAQ: SBRA) announced today the tax treatment for its 2025 distributions. The following table summarizes, for income tax purposes, the nature of cash distributions paid: Sabra Health Care REIT, Inc. Common Stock (CUSIP # 78573L106) Record Date Payable Date Distribution per Share   Total Ordinary Dividends   Non-Qualified Dividends   Qualified Dividends   Non-Dividend Distributions 02/14/2025 02/28/2025 $ 0.3000000   $ 0.2438846  .

In November, we (my wife and I) received a dividend income total of $1,489.90. Another $1,000+. Capital One Financial. After they acquired Discover, I was not sure what to expect.

TUSTIN, Calif.--(BUSINESS WIRE)---- $CIO #CIO--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced that Darrin Smith has been appointed Sabra's Chief Investment Officer, Secretary and Executive Vice President, effective January 1, 2026. Mr. Smith succeeds Talya Nevo-Hacohen, Sabra's former Chief Investment Officer, Treasurer and Executive Vice President in connection with her retirement on December 31, 2025. From March 2020 until his appointment as Chief Investment Officer, Mr. Smith served.